WHO prequalifies Sanofi and DNDi's malaria combination
This article was originally published in Scrip
Executive Summary
A fixed-dose combination to treat malaria developed by Sanofi-Aventisand the Drugs for Neglected Disease initiative (DNDi) has been added to the World Health Organization's (WHO) prequalification list.